Therapy Areas: Cardiovascular
Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama to Cover Non-Invasive HeartFlow FFRct Analysis
1 September 2017 - - Redwood City, California-based non-invasive cardiovascular disease diagnosis specialist HeartFlow, Inc. has received positive medical policies from Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama for the HeartFlow FFRct Analysis, a noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD), the company said.
These three health plans, which provide health insurance for a total of 44 million people, assessed the technical performance, diagnostic accuracy, clinical utility and clinical benefits of the HeartFlow FFRct Analysis.
After reviewing the evidence, they each determined that, when necessary, the use of HeartFlow's noninvasive FFRct technology following a coronary computed tomography angiogram is considered medically necessary for its members with stable chest pain.
The HeartFlow FFRct Analysis is a non-invasive technology that provides insight into both the extent of CAD and the impact of the disease on blood flow to the heart.
HeartFlow leverages deep learning to create a personalized, digital 3D model of the patient's coronary arteries. It then uses computer algorithms to simulate blood flow and assess the impact of blockages on coronary blood flow.
This technology has been demonstrated to reduce unnecessary and invasive diagnostic coronary angiography procedures, which can be associated with bleeding, stroke, major blood vessel damage and other serious complications. It also significantly reduces healthcare costs for hospitals.
HeartFlow's FFRct Analysis is the first available non-invasive solution that enables a physician to more appropriately evaluate whether an individual has significant coronary artery disease based on both anatomy and physiology. It is commercially available in the United States, Canada, Europe, and Japan.


Related Headlines